Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nexentis Technologies Inc.NITO · Entity 8476 | Director | December 23, 2024 | December 26, 2024 |
| Polyrizon Ltd.PLRZ · Entity 7474 | Director | March 18, 2026 | March 18, 2026 |
| SciSparc Ltd.SPRC · Entity 8412 | Director | March 18, 2026 | July 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nexentis Technologies Inc.
Report date December 23, 2024 · Filed December 26, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Shares of Common StockSEC Table I · non-derivative | Direct | 50,000 |
Reported balance
After 2024-12-23 transaction · row 1
1 source rowRow 1 · 2024-12-23 · Grant · Acquired 50,000 · Balance 50,000 F1: These restricted shares of common were issued to the Reporting Person in accordance with the Save Foods, Inc. 2022 Share Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted shares of common were issued to the Reporting Person in accordance with the Save Foods, Inc. 2022 Share Incentive Plan.
Polyrizon Ltd.
Report date March 18, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 2 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2 F1: These ordinary shares represent restricted ordinary shares, which vest in 7 equal quarterly installments on a quarterly basis beginning on April 30, 2026, subject to the Reporting Person's continued service. F3: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Polyrizon Ltd. Amended and Restated Equity Incentive Plan must be registered in the name of a trustee. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 3,646 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,646 F2: These ordinary shares represent restricted ordinary shares, of which (1) 521 ordinary shares are vested and (2) 3,125 restricted ordinary shares vest in 6 equal quarterly installments on a quarterly basis beginning on March 31, 2026, subject to the Reporting Person's continued service. F3: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Polyrizon Ltd. Amended and Restated Equity Incentive Plan must be registered in the name of a trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: These ordinary shares represent restricted ordinary shares, which vest in 7 equal quarterly installments on a quarterly basis beginning on April 30, 2026, subject to the Reporting Person's continued service.
F2: These ordinary shares represent restricted ordinary shares, of which (1) 521 ordinary shares are vested and (2) 3,125 restricted ordinary shares vest in 6 equal quarterly installments on a quarterly basis beginning on March 31, 2026, subject to the Reporting Person's continued service.
F3: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Polyrizon Ltd. Amended and Restated Equity Incentive Plan must be registered in the name of a trustee.
SciSparc Ltd.
Report date March 18, 2026 · Filed July 13, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 3,649 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 3,649 F1: This Form is filed solely as an amendment to the Form 3 filed on March 18, 2026. This amendment amends the total number of securities beneficially owned by the reporting person in Table I, and amends and restates the first footnote in Table I as follows: "Includes (i) 3,333 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in quarterly installments of 417 Ordinary Shares through December 18, 2027; and (ii) 316 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 40 Ordinary Shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share." |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31,941.00 · Expires 2028-01-03 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · Balance Not disclosed F2: This amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form is filed solely as an amendment to the Form 3 filed on March 18, 2026. This amendment amends the total number of securities beneficially owned by the reporting person in Table I, and amends and restates the first footnote in Table I as follows: "Includes (i) 3,333 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in quarterly installments of 417 Ordinary Shares through December 18, 2027; and (ii) 316 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 40 Ordinary Shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share."
F2: This amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 23, 2024 Filed Dec 26, 2024 12:42 UTC | Nexentis Technologies Inc. NITO · Entity 8476 | GrantRestricted Shares of Common Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-052016 · ownership.xml · nonDerivative · entry 1 Sidi Liat · CIK 0001973248 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 F1 · shares: These restricted shares of common were issued to the Reporting Person in accordance with the Save Foods, Inc. 2022 Share Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.